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A 31-year-old man came to our hospital with chest pain and was diagnosed to have a left testicular
tumor with metastasis to the lung, and cervical, mediastinal, and retroperitoneal lymph nodes. Left
orchiectomy was performed, and histological diagnosis was seminoma. Serum tumor markers were
normalized after 3rd-line chemotherapy, but lymph node metastases were still enlarged. Then the
cervical lymph node was excised, and histologically diagnosed as mature teratoma. Based on these results,
we diagnosed this case as growing teratoma syndrome. Since the whole metastasis was too large to be
completely excised, we started systemic interferon alfa-2b (Intron ○R A) administration. The metastasis
initially responded to the therapy by 20% reduction in size and remained stable thereafter. However, the
mediastinal lesion caused obstructive pneumonia, which was bronchoscopically resected. At the time of 12
years after the initial presentation, the tumors are well controlled with stable disease or only modest increase.
(Hinyokika Kiyo 61 : 163-166, 2015)
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** 現 : 宮崎大学泌尿器科
症 例
患 者 : 31歳，男性
主 訴 : 胸痛
既往歴 : 虫垂炎，中耳炎








pT1N3M1aS3，病期 IIIC で，IGCCC のリスク分類で
は good risk 群であった．術後 4日目より化学療法開
始．施行した化学療法のレジメンと転移巣のサイズの
経過を Fig. 1 に示す．
HCGβ は三次化学療法の後に陰性化をみたが，画
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Fig. 1. Time course of the size of metastasis. EP : etoposide and cisplatin, ICE : ifosfamide, carboplatin, and
etoposide, TIP : paclitaxel, ifosfamide, and cisplatin, Ir-DIP : irinotecan-docetaxel, ifosfamide, and cisplatin, Ir-
Neda : irinotecan and nedaplatin.
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Fig. 2. HE stain of the cervical lymphnode ; mature
cartilage, mucinous epithelium and smooth
muscle components were seen. Immature
component or other histologic types of germ










経過をみたが，腫瘍は増大したため， 9月 IFN 600万
























Rustin らは10例の奇形種患者に対し IFNα を投与
し，そのうち未分化奇形種の患者のみ病勢安定∼部分









Fig. 3. CT images of metastasis ; arrows indicate metastases. A) Neck lymph node ; Left, at diagnosis ; right, at
excision. B) Lung metastasis ; left, at diagnosis, middle, before interferon, right, at present. C) Mediastinal
metastasis ; left, at diagnosis, middle, before interferon, right, at present. D) Retroperitoneal metastasis ; left, at












GTS 症例においても，全身療法である IFNα に加え
て，有症状への局所療法を適宜併用することで，長期
の安定および生存を期待できる可能性を示唆している
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Fig. 4. Images during bronchoscopic surgery ; left, before excision ; right, after excision. The arrow
indicates obstruction.
と考える．
























teratoma syndrome の 1例を報告した．
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